Andreas Herrmann is a prominent figure in the field of longevity, currently serving as the Chief Executive Officer at Corat Therapeutics, a subsidiary of Baliopharm. With a strong background in biotechnology and pharmaceutical development, he leads innovative research aimed at enhancing healthspan and lifespan. Herrmann is dedicated to advancing cutting-edge therapies that address age-related diseases and promote healthy aging. His leadership and vision position Corat Therapeutics at the forefront of the longevity movement in Switzerland and beyond.